首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   1313750篇
  免费   102552篇
  国内免费   2208篇
耳鼻咽喉   18966篇
儿科学   45290篇
妇产科学   36103篇
基础医学   187040篇
口腔科学   34956篇
临床医学   115566篇
内科学   265280篇
皮肤病学   28715篇
神经病学   104138篇
特种医学   52673篇
外国民族医学   660篇
外科学   201244篇
综合类   27311篇
现状与发展   1篇
一般理论   415篇
预防医学   98333篇
眼科学   28469篇
药学   97541篇
  3篇
中国医学   2393篇
肿瘤学   73413篇
  2019年   9964篇
  2018年   14159篇
  2017年   10900篇
  2016年   12027篇
  2015年   13531篇
  2014年   18731篇
  2013年   28468篇
  2012年   39359篇
  2011年   41543篇
  2010年   24905篇
  2009年   23744篇
  2008年   39537篇
  2007年   42364篇
  2006年   42346篇
  2005年   41327篇
  2004年   40221篇
  2003年   38818篇
  2002年   37965篇
  2001年   64244篇
  2000年   66602篇
  1999年   56430篇
  1998年   14763篇
  1997年   13317篇
  1996年   13700篇
  1995年   13689篇
  1994年   12992篇
  1993年   11997篇
  1992年   44701篇
  1991年   43656篇
  1990年   42389篇
  1989年   40284篇
  1988年   37045篇
  1987年   36371篇
  1986年   33746篇
  1985年   32462篇
  1984年   24280篇
  1983年   20365篇
  1982年   11860篇
  1981年   10786篇
  1979年   21400篇
  1978年   14900篇
  1977年   12610篇
  1976年   11758篇
  1975年   12698篇
  1974年   14719篇
  1973年   14163篇
  1972年   12979篇
  1971年   11757篇
  1970年   11070篇
  1969年   10031篇
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
Neuroscience and Behavioral Physiology - We present here results from analysis of the formation of brain bioelectrical activity in children and adolescents living in the northern region of Russia...  相似文献   
2.
Oral squamous cell carcinomas (OSCCs) develop in genetically altered epithelium in the mucosal lining, also coined as fields, which are mostly not visible but occasionally present as white oral leukoplakia (OL) lesions. We developed a noninvasive genetic assay using next-generation sequencing (NGS) on brushed cells to detect the presence of genetically altered fields, including those that are not macroscopically visible. The assay demonstrated high accuracy in OL patients when brush samples were compared with biopsies as gold standard. In a cohort of Fanconi anemia patients, detection of mutations in prospectively collected oral brushes predicted oral cancer also when visible abnormalities were absent. We further provide insight in the molecular landscape of OL with frequent changes of TP53, FAT1 and NOTCH1. NGS analysis of noninvasively collected samples offers a highly accurate method to detect genetically altered fields in the oral cavity, and predicts development of OSCC in high-risk individuals. Noninvasive genetic screening can be employed to screen high-risk populations for cancer and precancer, map the extension of OL lesions beyond what is visible, map the oral cavity for precancerous changes even when visible abnormalities are absent, test accuracy of promising imaging modalities, monitor interventions and determine genetic progression as well as the natural history of the disease in the human patient.  相似文献   
3.
4.
5.
6.
7.
8.
The Dutch Drug Rediscovery Protocol (DRUP) and the Australian Cancer Molecular Screening and Therapeutic (MoST) Program are similar nonrandomized, multidrug, pan-cancer trial platforms that aim to identify signals of clinical activity of molecularly matched targeted therapies or immunotherapies outside their approved indications. Here, we report results for advanced or metastatic cancer patients with tumors harboring cyclin D-CDK4/6 pathway alterations treated with CDK4/6 inhibitors palbociclib or ribociclib. We included adult patients that had therapy-refractory solid malignancies with the following alterations: amplifications of CDK4, CDK6, CCND1, CCND2 or CCND3, or complete loss of CDKN2A or SMARCA4. Within MoST, all patients were treated with palbociclib, whereas in DRUP, palbociclib and ribociclib were assigned to different cohorts (defined by tumor type and alteration). The primary endpoint for this combined analysis was clinical benefit, defined as confirmed objective response or stable disease ≥16 weeks. We treated 139 patients with a broad variety of tumor types; 116 with palbociclib and 23 with ribociclib. In 112 evaluable patients, the objective response rate was 0% and clinical benefit rate at 16 weeks was 15%. Median progression-free survival was 4 months (95% CI: 3-5 months), and median overall survival 5 months (95% CI: 4-6 months). In conclusion, only limited clinical activity of palbociclib and ribociclib monotherapy in patients with pretreated cancers harboring cyclin D-CDK4/6 pathway alterations was observed. Our findings indicate that monotherapy use of palbociclib or ribociclib is not recommended and that merging data of two similar precision oncology trials is feasible.  相似文献   
9.
Medicine, Health Care and Philosophy - In this paper, I will provide a phenomenological analysis of somatic obsessions at times present in obsessive–compulsive disorder. I will compare two...  相似文献   
10.
Die Anaesthesiologie - Phantomschmerzen haben eine hohe Prävalenz nach Majoramputationen und sind mit einer zusätzlichen Einschränkung der Lebensqualität verbunden....  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号